Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

OHANA KIDS & FAMILY KARE LLC

NPI: 1003356320 · MESA, AZ 85204 · Family Medicine Physician · NPI assigned 03/06/2017

$4.75M
Total Medicaid Paid
106,935
Total Claims
97,082
Beneficiaries
73
Codes Billed
2021-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLOPEZ, LUZ (PRESIDENT)
NPI Enumeration Date03/06/2017

Related Entities

Other providers sharing the same authorized official: LOPEZ, LUZ

ProviderCityStateTotal Paid
KIDS KARE PEDIATRICS PC PHOENIX AZ $4.73M
DR GRABOWSKI PC BELLEVUE WA $122K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 11,193 $400K
2022 30,786 $1.49M
2023 34,926 $1.52M
2024 30,030 $1.33M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 26,157 22,817 $1.41M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 13,116 11,901 $985K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 2,728 293 $787K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2,857 2,851 $231K
90460 Immunization administration through 18 years of age via any route, first or only component 5,409 5,315 $222K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,409 2,403 $213K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2,268 2,260 $181K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1,937 1,904 $144K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1,028 1,022 $95K
92567 4,798 4,769 $68K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 784 777 $54K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 179 173 $36K
99385 335 332 $35K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 314 311 $29K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,822 1,790 $25K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 732 714 $23K
36415 Collection of venous blood by venipuncture 7,219 6,971 $22K
99000 3,667 3,431 $18K
96127 4,170 4,144 $18K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,236 1,198 $17K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 484 470 $16K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,179 1,125 $16K
99173 5,846 5,654 $13K
92551 1,070 1,064 $11K
96110 Developmental screening, with scoring and documentation, per standardized instrument 437 436 $10K
96160 4,073 3,993 $10K
95115 1,074 440 $10K
99383 92 91 $8K
99401 191 185 $6K
95117 412 197 $5K
0002A 47 46 $4K
99188 362 357 $4K
54450 55 55 $4K
93000 265 264 $3K
81002 1,100 1,044 $3K
0071A 38 38 $3K
99384 27 27 $3K
99382 25 25 $2K
94010 66 62 $2K
99386 13 13 $2K
0072A 21 21 $1K
0001A 14 14 $1K
99381 13 13 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 57 57 $628.09
94760 2,190 1,834 $453.36
94664 30 29 $414.79
J0696 Injection, ceftriaxone sodium, per 250 mg 354 346 $391.58
99408 89 79 $311.43
81025 26 26 $158.78
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 13 13 $20.84
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 27 26 $5.37
3077F 16 13 $0.00
90734 331 306 $0.00
90670 981 879 $0.00
90633 417 372 $0.00
90707 27 25 $0.00
90715 91 84 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 136 115 $0.00
90671 86 69 $0.00
3078F 13 13 $0.00
90710 13 13 $0.00
90696 41 41 $0.00
90698 345 330 $0.00
90651 230 208 $0.00
90677 27 27 $0.00
90686 275 249 $0.00
90680 506 449 $0.00
3074F 13 13 $0.00
90697 227 189 $0.00
90744 44 44 $0.00
3008F 196 166 $0.00
90716 44 37 $0.00
1170F 21 20 $0.00